Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Kasper van de Born"'
Autor:
Adrianus C. Laan, Godefridus J. Peters, Richard J. Honeywell, P. Noordhuis, Kasper van de Born
Publikováno v:
International Journal of Molecular Sciences
Volume 20
Issue 15
International Journal of Molecular Sciences, 20(15). Multidisciplinary Digital Publishing Institute (MDPI)
International Journal of Molecular Sciences, Vol 20, Iss 15, p 3619 (2019)
Noordhuis, P, Laan, A C, van de Born, K, Honeywell, R J & Peters, G J 2019, ' Coexisting Molecular Determinants of Acquired Oxaliplatin Resistance in Human Colorectal and Ovarian Cancer Cell Lines ', International Journal of Molecular Sciences, vol. 20, no. 15 . https://doi.org/10.3390/ijms20153619
Volume 20
Issue 15
International Journal of Molecular Sciences, 20(15). Multidisciplinary Digital Publishing Institute (MDPI)
International Journal of Molecular Sciences, Vol 20, Iss 15, p 3619 (2019)
Noordhuis, P, Laan, A C, van de Born, K, Honeywell, R J & Peters, G J 2019, ' Coexisting Molecular Determinants of Acquired Oxaliplatin Resistance in Human Colorectal and Ovarian Cancer Cell Lines ', International Journal of Molecular Sciences, vol. 20, no. 15 . https://doi.org/10.3390/ijms20153619
Oxaliplatin (OHP) treatment of colorectal cancer (CRC) frequently leads to resistance. OHP resistance was induced in CRC cell lines LoVo-92 and LoVo-Li and a platinum-sensitive ovarian cancer cell line, A2780, and related to cellular platinum accumul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e12b53cf78723e5991c6c4fddbd0fd9
Autor:
Nienke Losekoot, Godefridus J. Peters, Kasper van de Born, Adri C. Laan, P. Noordhuis, Ietje Kathmann
Publikováno v:
Noordhuis, P, Laan, A C, van der Born, K, Losekoot, N, Kathmann, I & Peters, G J 2008, ' Oxaliplatin activity in selected and unselected human ovarian and colorectal cancer cell lines ', Biochemical Pharmacology, vol. 76, no. 1, pp. 53-61 . https://doi.org/10.1016/j.bcp.2008.04.007
Biochemical Pharmacology, 76(1), 53-61. Elsevier Inc.
Biochemical Pharmacology, 76(1), 53-61. Elsevier Inc.
Oxaliplatin is used for treatment of colon cancer in combination with 5-fluorouracil or irinotecan. Oxaliplatin has similar, but also different resistant mechanisms as cisplatin. We studied the activity of oxaliplatin in ovarian and colon cancer cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7b193c23841174966b6bf13ef95ac05
https://research.vumc.nl/en/publications/bbb32d7f-5140-414c-9af9-6c812966f87f
https://research.vumc.nl/en/publications/bbb32d7f-5140-414c-9af9-6c812966f87f
